These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3775691)

  • 21. Single-dose pharmacodynamics of clopidogrel.
    Thebault JJ; Kieffer G; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():3-8. PubMed ID: 10440415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial.
    Gouya G; Jilma B; Niel M; Eichelberger B; Wolzt M; Panzer S
    Platelets; 2009 May; 20(3):171-6. PubMed ID: 19437334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam and bleeding disorders.
    Boon P; Hulhoven R; Offner F
    Acta Neurol Belg; 2007 Dec; 107(4):97-102. PubMed ID: 18416281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers.
    Pellegrini N; Pareti FI; Stabile F; Brusamolino A; Simonetti P
    Eur J Clin Nutr; 1996 Apr; 50(4):209-13. PubMed ID: 8730606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action of Trivé 1000 on hemostasis and hematocrit].
    Fogliani J; Siccardi F; Ruggieri F
    Ann Anesthesiol Fr; 1977; 18(2):214-22. PubMed ID: 18968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction.
    Jámbor C; Weber CF; Gerhardt K; Dietrich W; Spannagl M; Heindl B; Zwissler B
    Anesth Analg; 2009 Jul; 109(1):25-31. PubMed ID: 19439684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
    Savcic M; Hauert J; Bachmann F; Wyld PJ; Geudelin B; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():15-9. PubMed ID: 10440417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in platelet function testing has a major influence on detection of aspirin resistance in healthy subjects.
    Bozic-Mijovski M; Rakusa M; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):84-90. PubMed ID: 19127088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Exploring the effect of aspirin on primary hemostasis through bleeding time. Study of 16 volunteers].
    Gargouri J; Mnif H; Sellami S; Rekik H
    Tunis Med; 2004 Feb; 82(2):219-22. PubMed ID: 15185599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect on the capillary resistance, time of hemorrhage and coagulation of an escin-cyclonamine association].
    De Pascale V; Lavezzari E; Bamonte F; Craveri F; Lecchini S; Crema A
    Boll Chim Farm; 1974 Dec; 113(12):660-73. PubMed ID: 4464907
    [No Abstract]   [Full Text] [Related]  

  • 36. A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day).
    Undas A; Undas R; Musiał J; Szczeklik A
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):231-4. PubMed ID: 10870801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists.
    Sermet A; Aybak M; Ulak G; Güzel C; Denli O
    Arzneimittelforschung; 1995 Jan; 45(1):19-21. PubMed ID: 7893263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ethamsylate on cerebral blood flow velocity in premature babies.
    Rennie JM; Lam PK
    Arch Dis Child; 1989 Jan; 64(1 Spec No):46-7. PubMed ID: 2647043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Operative blood loss and the frequency of haemorrhage associated with adenotonsillectomy in children: a double-blind trial of ethamsylate.
    Arora YR; Manford ML
    Br J Anaesth; 1979 Jun; 51(6):557-61. PubMed ID: 380611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers.
    Sonksen JR; Kong KL; Holder R
    Br J Anaesth; 1999 Mar; 82(3):360-5. PubMed ID: 10434816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.